Is assessing kidney function with serum creatinine and then electrolytes and Blood Urea Nitrogen (BUN) a good practice in cost-sensitive areas?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 20, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Assessing Kidney Function in Cost-Sensitive Areas: A Stepwise Approach

Starting with serum creatinine before proceeding to electrolytes and BUN is an appropriate and cost-effective approach for kidney function assessment in resource-limited settings. 1

Evidence-Based Approach to Kidney Function Assessment

Initial Assessment

  • Serum creatinine is the primary test for initial kidney function assessment
    • Provides estimation of glomerular filtration rate (eGFR)
    • Low cost and widely available globally 1
    • Should be used as the first-line test in cost-sensitive areas

Stepwise Testing Algorithm

  1. First step: Measure serum creatinine to estimate GFR
  2. Second step: Add electrolytes if abnormal creatinine or clinical suspicion warrants
  3. Third step: Add BUN if further assessment of kidney function is needed

Cost Considerations in Resource-Limited Settings

The KDIGO Controversies Conference specifically addressed this issue, recognizing that:

  • The cost of measuring multiple kidney markers simultaneously may be prohibitive in low and middle-income countries (LMICs) 1
  • In resource-limited settings, creatinine testing alone is an acceptable first step 1
  • This stepwise approach allows for appropriate resource allocation while still providing essential clinical information

Adapting Testing Based on Resource Availability

For Low-Resource Settings

  • Creatinine testing alone as initial screen is appropriate 1
  • Dipstick testing for albuminuria can be added as a low-cost complement if proteinuria is suspected 1
  • Follow up with electrolytes and BUN only when indicated by abnormal creatinine or clinical presentation

For Higher-Resource Settings

  • The "triple marker" panel (creatinine, cystatin C, and urine albumin-to-creatinine ratio) provides more comprehensive assessment 1
  • However, this is primarily recommended for high-income settings where cost constraints are less significant 1

Clinical Implications and Considerations

Benefits of the Stepwise Approach

  • Reduces unnecessary testing costs
  • Focuses resources on patients most likely to benefit from additional testing
  • Aligns with global recommendations for cost-effective CKD screening 1, 2

Limitations to Consider

  • Serum creatinine alone has limitations in accurately estimating GFR 3
  • May miss early kidney disease if not combined with albuminuria testing 4
  • In patients with complex conditions (e.g., complex stones, abnormal anatomy), additional testing may be required regardless of cost constraints 1

Implementation Guidance

  • Use local laboratory reference ranges for interpretation
  • Consider point-of-care creatinine testing in settings where laboratory access is limited 5
  • For patients with suspected kidney stones or urological conditions, follow the stepwise approach but have a lower threshold for additional testing 1

This stepwise approach to kidney function assessment balances clinical necessity with resource constraints, making it particularly suitable for cost-sensitive healthcare environments while still providing essential diagnostic information for patient care.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.